Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of $1.09 billion. The enterprise value is $1.41 billion.
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Teladoc Health has 177.47 million shares outstanding. The number of shares has increased by 3.59% in one year.
| Current Share Class | 177.47M |
| Shares Outstanding | 177.47M |
| Shares Change (YoY) | +3.59% |
| Shares Change (QoQ) | +0.58% |
| Owned by Insiders (%) | 1.12% |
| Owned by Institutions (%) | 70.55% |
| Float | 175.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| Forward PS | 0.42 |
| PB Ratio | 0.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.90 |
| P/OCF Ratio | 3.74 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 87.14, with an EV/FCF ratio of 5.03.
| EV / Earnings | n/a |
| EV / Sales | 0.56 |
| EV / EBITDA | 87.14 |
| EV / EBIT | n/a |
| EV / FCF | 5.03 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.75.
| Current Ratio | 2.70 |
| Quick Ratio | 2.33 |
| Debt / Equity | 0.75 |
| Debt / EBITDA | 37.51 |
| Debt / FCF | 3.72 |
| Interest Coverage | -8.26 |
Financial Efficiency
Return on equity (ROE) is -15.42% and return on invested capital (ROIC) is -4.04%.
| Return on Equity (ROE) | -15.42% |
| Return on Assets (ROA) | -3.48% |
| Return on Invested Capital (ROIC) | -4.04% |
| Return on Capital Employed (ROCE) | -7.22% |
| Revenue Per Employee | $459,673 |
| Profits Per Employee | -$40,652 |
| Employee Count | 5,500 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 19.86 |
Taxes
| Income Tax | -26.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.23% in the last 52 weeks. The beta is 2.05, so Teladoc Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.05 |
| 52-Week Price Change | -32.23% |
| 50-Day Moving Average | 7.23 |
| 200-Day Moving Average | 7.59 |
| Relative Strength Index (RSI) | 31.79 |
| Average Volume (20 Days) | 5,517,792 |
Short Selling Information
The latest short interest is 24.74 million, so 13.94% of the outstanding shares have been sold short.
| Short Interest | 24.74M |
| Short Previous Month | 25.72M |
| Short % of Shares Out | 13.94% |
| Short % of Float | 14.10% |
| Short Ratio (days to cover) | 6.07 |
Income Statement
In the last 12 months, Teladoc Health had revenue of $2.53 billion and -$223.59 million in losses. Loss per share was -$1.28.
| Revenue | 2.53B |
| Gross Profit | 1.76B |
| Operating Income | -178.59M |
| Pretax Income | -250.08M |
| Net Income | -223.59M |
| EBITDA | 16.17M |
| EBIT | -178.59M |
| Loss Per Share | -$1.28 |
Full Income StatementBalance Sheet
The company has $726.25 million in cash and $1.04 billion in debt, with a net cash position of -$315.82 million or -$1.78 per share.
| Cash & Cash Equivalents | 726.25M |
| Total Debt | 1.04B |
| Net Cash | -315.82M |
| Net Cash Per Share | -$1.78 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 7.85 |
| Working Capital | 687.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $292.52 million and capital expenditures -$12.41 million, giving a free cash flow of $280.11 million.
| Operating Cash Flow | 292.52M |
| Capital Expenditures | -12.41M |
| Free Cash Flow | 280.11M |
| FCF Per Share | $1.58 |
Full Cash Flow StatementMargins
Gross margin is 69.80%, with operating and profit margins of -7.06% and -8.84%.
| Gross Margin | 69.80% |
| Operating Margin | -7.06% |
| Pretax Margin | -9.89% |
| Profit Margin | -8.84% |
| EBITDA Margin | 0.64% |
| EBIT Margin | -7.06% |
| FCF Margin | 11.08% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.59% |
| Shareholder Yield | -3.59% |
| Earnings Yield | -20.45% |
| FCF Yield | 25.62% |
Analyst Forecast
The average price target for Teladoc Health is $9.42, which is 52.92% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.42 |
| Price Target Difference | 52.92% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 2.32% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -6.41 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.41 |
| Piotroski F-Score | 4 |
